QL
PTCT icon

Quarry LP’s PTC Therapeutics PTCT Stock Holding History

Quarry LP’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28K Sell
28
-1,222
-98% -$88.2K ﹤0.01% 1555
2026
Q1 		$85.2K Sell
1,250
-2,615
-68% -$185K 0.02% 534
2025
Q4 		$294K Buy
3,865
+3,561
+1,171% +$259K 0.05% 223
2025
Q3 		$18.7K Buy
+304
New +$15.8K ﹤0.01% 1448
2024
Q4 		– Sell
-5,000
Closed -$186K – 1937
2024
Q3 		$186K Hold
5,000
– – 0.05% 250
2024
Q2 		$153K Buy
5,000
+2,500
+100% +$81K 0.04% 219
2024
Q1 		$72.7K Buy
+2,500
New +$70K 0.01% 311

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Quarry LP's PTCT Position: Q2 2026 in Review

Quarry LP reduced its PTC Therapeutics (PTCT) stake by 98% in Q2 2026, selling an estimated $88.2K and leaving 28 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #1555.

Quarry LP first reported a position in PTCT in Q1 2024 and has held it in 7 quarters since. The position peaked at $294K in Q4 2025. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Quarry LP held 28 shares of PTC Therapeutics worth $2.28K as of Q2 2026.
  • Quarry LP sold 1,222 PTC Therapeutics shares in Q2 2026, an estimated $88.2K.
  • PTC Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1555 holding.
  • Quarry LP first reported a position in PTC Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • Quarry LP's PTC Therapeutics position peaked at $294K in Q4 2025.
  • 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.